Desloratadine/pseudoephedrine

Last updated

Desloratadine/pseudoephedrine
Combination of
Desloratadine Antihistamine
Pseudoephedrine Decongestant
Clinical data
Trade names Clarinex-D, Aerinaze
AHFS/Drugs.com Micromedex Detailed Consumer Information
License data
Routes of
administration 		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis. [1] [2]

Contents

Desloratadine/pseudoephedrine was approved for use in the United States in 2005 [1] [3] and in the European Union in July 2007. [2]

Medical uses

Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion. [2]

References

  1. 1 2 3 "Clarinex-D 12 Hour- desloratadine and pseudoephedrine sulfate tablet, extended release". DailyMed. 15 March 2019. Archived from the original on 16 February 2020. Retrieved 1 March 2020.
  2. 1 2 3 4 "Aerinaze EPAR". European Medicines Agency. 3 August 2007. Archived from the original on 2 March 2020. Retrieved 1 March 2020.
  3. ↑ "Drug Approval Package: Clarinex-D 24 Hour (Desloratadine/Pseudoephedrine Sulfate) NDA #021605". U.S. Food and Drug Administration (FDA). 9 May 2007. Archived from the original on 2 March 2020. Retrieved 1 March 2020.

Further reading


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.